ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Psychiatric/Mental Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,955Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 29

$1.52M Total Retail Price of All Prescriptions

Rank: 1 out of 29

380 Patients Receiving at Least One Drug in Part D
27%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 1,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$191 was the average price of a prescription from this provider, compared to $158 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
ABILIFY 433 45 1 1
RISPERIDONE 367 114 2 2
OLANZAPINE 344 51 3 9
BENZTROPINE MESYLATE 332 36 R 4 8
LAMOTRIGINE 314 67 5 3
CYMBALTA 287 99 6 7
QUETIAPINE FUMARATE 247 78 7 5
SERTRALINE HCL 240 88 8 6
FAZACLO 228 13 9 29
ZOLPIDEM TARTRATE 223 19 10 11
GABAPENTIN 202 82 11 24
ZIPRASIDONE HCL 193 20 12 19
METHYLPHENIDATE HCL 191 70 13 37
TRAZODONE HCL 191 14 13 4
CITALOPRAM HBR 178 28 15 12
ESCITALOPRAM OXALATE 154 43 16 15
BUSPIRONE HCL 154 46 16 20
AMPHETAMINE SALT COMBO 146 15 S2 18 27
VENLAFAXINE HCL ER 146 50 18 10
FLUOXETINE HCL 145 49 20 17
BUPROPION XL 133 22 21 16
LITHIUM CARBONATE 128 0 22 14
SEROQUEL XR 126 0 23 22
DIVALPROEX SODIUM 122 38 24 32
INVEGA SUSTENNA 117 0 25 36
DIVALPROEX SODIUM ER 113 0 26 13
TOPIRAMATE 110 0 27 18
NAMENDA 106 83 28 39
MIRTAZAPINE 96 42 29 23
BUPROPION HCL SR 91 0 30 31
FLUVOXAMINE MALEATE 89 0 31 35
SEROQUEL 78 23 32 25
INVEGA 76 0 33 30
RISPERDAL CONSTA 75 0 34 28
ZYPREXA 73 11 35 49
OXCARBAZEPINE 70 0 36 34
PAROXETINE HCL 70 20 36 26
DONEPEZIL HCL 61 36 38 41
AMITRIPTYLINE HCL 60 0 R 39 44
DEXTROAMPHETAMINE-AMPHETAMINE 54 0 S2 40 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.